Dissecting a population genome for targeted screening of disease mutations.

Compared to mixed populations, population isolates such as Finland show distinct differences in the prevalence of disease mutations. However, little information exists of the differences on the prevalence of different disease alleles in regional populations with different history of multiple bottlenecks. We constructed a DNA-array and monitored the prevalence of 31 rare and common disease mutations underlying 27 clinical phenotypes in a large population-based study sample. Over 64 000 genotypes were assigned in 2151 samples from four geographical areas representing early and late settlement regions of Finland. Each sample was analyzed in duplicate and a total of 142 000 array-derived genotyping calls were made. On average one in three individuals was found to be a carrier of one of the 31 monitored mutations. This should remove fears of the stigmatizing effect of a carrier-screening program monitoring multiple diseases. Regional differences were found in the prevalence of mutations, providing molecular evidence for the deviating population histories of regional subisolates. The mutations introduced early into the population revealed relatively even distribution in different subregions. More recently introduced rare mutations showed local clustering of disease alleles, indicating the persistence of population subisolates and the effect of multiple bottlenecks in molding the population gene pool. Regional differences were observed also for common disease alleles. Such precise information of the carrier frequencies could form the basis for targeted genetic screens in this population. Our approach describes a general paradigm for large-scale carrier-screening programs also in other populations.

[1]  K Holli,et al.  Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. , 2000, Journal of the National Cancer Institute.

[2]  L. Peltonen,et al.  A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. , 2000, Genome research.

[3]  E. Romppanen,et al.  Detection of the Finnish-type congenital nephrotic syndrome by restriction fragment length polymorphism and dual-color oligonucleotide ligation assays. , 2000, Clinical chemistry.

[4]  A Chakravarti,et al.  Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. , 2000, Genome research.

[5]  S. Antonarakis,et al.  OMIM passes the 1,000-disease-gene mark , 2000, Nature Genetics.

[6]  B. Guldbrandtsen,et al.  POPDIST, version 1.1.1: a program to calculate population genetic distance and identity measures. , 2000, The Journal of heredity.

[7]  Peter J. van der Spek,et al.  A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases , 1999, Nature Genetics.

[8]  T. Varilo.  The age of the mutations in the Finnish disease heritage; a genealogical and linkage disequilibrium study , 1999 .

[9]  A. Chapelle,et al.  The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8 , 1999, Nature Genetics.

[10]  Earl Hubbell,et al.  Genome-wide mapping with biallelic markers in Arabidopsis thaliana , 1999, Nature Genetics.

[11]  F. Collins,et al.  Mutational analysis using oligonucleotide microarrays , 1999, Journal of medical genetics.

[12]  T. Lakka,et al.  Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland. , 1999, Circulation.

[13]  N. Gerry,et al.  Universal DNA microarray method for multiplex detection of low abundance point mutations. , 1999, Journal of molecular biology.

[14]  R. Hegele,et al.  Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis , 1999, Nature Genetics.

[15]  A. Sajantila,et al.  Y chromosomal polymorphisms reveal founding lineages in the Finns and the Saami , 1999, European Journal of Human Genetics.

[16]  A. Chapelle,et al.  Three widespread founder mutations contribute to high incidence of X-linked juvenile retinoschisis in Finland , 1999, European Journal of Human Genetics.

[17]  D. Torrents,et al.  Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene , 1999, Nature Genetics.

[18]  S. P. Fodor,et al.  Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays. , 1998, Genome research.

[19]  F. Wright,et al.  Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Peltonen,et al.  Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. , 1998, Human molecular genetics.

[21]  E. Lander,et al.  CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis , 1998, Nature Genetics.

[22]  L. Aaltonen,et al.  Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.

[23]  C. Nusbaum,et al.  Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. , 1998, Science.

[24]  L. Peltonen,et al.  Dual origins of Finns revealed by Y chromosome haplotype variation. , 1998, American journal of human genetics.

[25]  L Peltonen,et al.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. , 1998, Molecular cell.

[26]  L. Peltonen,et al.  An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains , 1997, Nature Genetics.

[27]  K Kontula,et al.  Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[28]  C. Eng,et al.  Prenatal genetic carrier testing using triple disease screening. , 1997, JAMA.

[29]  X. Estivill,et al.  Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. , 1997, Human molecular genetics.

[30]  E. Beutler,et al.  HLA-H and Associated Proteins in Patients with Hemochromatosis , 1997, Molecular medicine.

[31]  L Peltonen,et al.  Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. , 1997, Genome research.

[32]  D. Kelsell,et al.  Connexin 26 mutations in hereditary non-syndromic sensorineural deafness , 1997, nature.

[33]  P. Munroe,et al.  Rapid diagnostic test for the major mutation underlying Batten disease. , 1996, Journal of medical genetics.

[34]  S. P. Fodor,et al.  Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two–colour fluorescence analysis , 1996, Nature Genetics.

[35]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[36]  Christer Holmberg,et al.  Mutations of the Down–regulated in adenoma (DRA) gene cause congenital chloride diarrhoea , 1996, Nature Genetics.

[37]  C. Scriver,et al.  Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools. , 1996, American journal of human genetics.

[38]  L. Peltonen,et al.  DNA-based carrier screening in primary healthcare: screening for aspartylglucosaminuria mutations in maternity health offices. , 1996, Clinical chemistry.

[39]  A. de la Chapelle,et al.  Phenylketonuria in a low incidence population: molecular characterisation of mutations in Finland. , 1995, Journal of medical genetics.

[40]  J. Haines,et al.  Isolation of a novel gene underlying batten disease, CLN3 , 1995, Cell.

[41]  L. Peltonen,et al.  Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis , 1995, Nature.

[42]  François Rousset,et al.  GENEPOP (version 1.2): population genetic software for exact tests and ecumenicism , 1995 .

[43]  Eric S. Lander,et al.  The diastrophic dysplasia gene encodes a novel sulfate transporter: Positional cloning by fine-structure linkage disequilibrium mapping , 1994, Cell.

[44]  E. Vartiainen,et al.  Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. , 1994, International journal of epidemiology.

[45]  J. Kaprio.  Lessons from twin studies in Finland. , 1994, Annals of medicine.

[46]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[47]  K. Narisawa,et al.  Identification of a common mutation in Finnish patients with nonketotic hyperglycinemia. , 1992, The Journal of clinical investigation.

[48]  L. Peltonen,et al.  Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland. , 1992, Genomics.

[49]  L. Peltonen,et al.  Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. , 1991, The EMBO journal.

[50]  A. Beaudet.  Carrier screening for cystic fibrosis. , 1990, American journal of human genetics.

[51]  J. Perheentupa,et al.  Hereditary diseases in Finland; rare flora in rare soul. , 1973, Annals of clinical research.

[52]  D. Groggel.  Practical Nonparametric Statistics , 1972, Technometrics.

[53]  J. Visakorpi,et al.  THE INCIDENCE OF PKU IN FINLAND , 1971, Acta paediatrica Scandinavica.

[54]  R. Guthrie,et al.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. , 1963, Pediatrics.

[55]  X. Estivill,et al.  High carrier frequency of the 35delG deafness mutation in European populations , 2000, European Journal of Human Genetics.

[56]  T Varilo,et al.  Molecular genetics of the Finnish disease heritage. , 1999, Human molecular genetics.

[57]  M. Margaglione,et al.  Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden). , 1999, Blood.

[58]  E. Lander,et al.  Characterization of single-nucleotide polymorphisms in coding regions of human genes , 1999, Nature Genetics.

[59]  E. Romppanen,et al.  Molecular diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by oligonucleotide ligation assay. , 1998, Clinical chemistry.

[60]  A. Palotie,et al.  [Genetic background and DNA diagnostics of hemochromatosis]. , 1998, Duodecim; laaketieteellinen aikakauskirja.

[61]  E. Sacchi,et al.  A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. , 1997, Blood.

[62]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[63]  S. M. Kim,et al.  Cystic fibrosis mutation detection by hybridization to light‐generated DNA probe arrays , 1996, Human mutation.

[64]  R. Crystal.  The α1-antitrypsin gene and its deficiency states , 1989 .

[65]  N. Saris,et al.  [The prevalence of serum alpha 1-antitrypsin deficiency in Finland]. , 1973, Duodecim; laaketieteellinen aikakauskirja.